As filed with the Securities and Exchange Commission on November 6, 2020
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
QUOTIENT LIMITED
(Exact name of registrant as specified in its charter)
| | |
Jersey, Channel Islands | | Not applicable |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
| | |
B1, Business Park Terre Bonne, Route de Crassier 13, 1262 Eysins, Switzerland 011-41-22-716-9800 | | Not applicable |
(Address of Principal Executive Offices) | | (ZIP Code) |
Inducement Share Option Award
(Full Title of the Plan)
Jeremy Stackawitz
Quotient Biodiagnostics, Inc.
301 South State Street, Suite S-204
Newtown, Pennsylvania 18940
(215) 497-8820
(Name, address and telephone number, including area code, of agent for service)
Copies to:
Per B. Chilstrom, Esq.
Clifford Chance US LLP
31 West 52nd Street
New York, NY 10019
(212) 878-8000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
| | | | | | |
Large accelerated filer | | ☐ | | Accelerated filer | | ☐ |
| | | |
Non-accelerated filer | | ☒ | | Smaller reporting company | | ☒ |
| | | |
| | | | Emerging growth company | | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
CALCULATION OF REGISTRATION FEE
| | | | | | | | |
|
Title of Securities to be Registered | | Amount to be Registered(1) | | Proposed Maximum Offering Price Per Share(2) | | Proposed Maximum Aggregate Offering Price(2) | | Amount of Registration Fee |
Ordinary shares of no par value | | | | | | | | |
— Inducement Share Option Award to Isabelle Buckle | | 20,790 shares(2) | | $4.81(3) | | $99,999.90(3) | | $10.91 |
— Inducement Share Option Award to Catherine Larue | | 20,790 shares(2) | | $4.81(3) | | $99,999.90(3) | | $10.91 |
TOTAL | | 41,580 shares | | — | | $199,999.80 | | $21.82 |
|
|
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional ordinary shares of no par value (“Ordinary Shares”), that become issuable in respect of the securities identified in the above table by reason of any share dividend, share split, recapitalization or similar transaction effected without the receipt of consideration that increases the number of outstanding Ordinary Shares. |
(2) | Consists of Ordinary Shares underlying options to purchase Ordinary Shares granted to Ms. Buckle and Ms. Larue on September 1, 2020 as an inducement material to each of Ms. Buckle’s and Ms. Larue’s joining the Board of Directors (the “Board”) of Quotient Limited (the “Registrant”), in accordance with the inducement grant exception under Nasdaq Rule 5635(c)(4). |
(3) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and Rule 457(h) promulgated under the Securities Act. The proposed maximum offering price per share is based on the price at which such option may be exercised, which was the closing price of a share of the Registrant’s Ordinary Shares on September 1, 2020 as reported on The Nasdaq Global Market. |